Literature DB >> 9127580

The effectiveness of inactivated, purified and concentrated experimental rabies vaccine for veterinary use: immunogenic activity.

J Süliová1, Z Benísek, S Svrcek, A Durove, R Ondrejka.   

Abstract

The authors prepared an experimental, inactivated, concentrated and highly purified rabies vaccine from the strain Vnukovo-32/107. The purification and concentration (simultaneous--in one operation) was carried out by affinity chromatography. The content of rabies antigen in the vaccine was 4.256 UE/cm3 (determined by ELISA method). The authors used their own lipoid adjuvant--type oil in water--to resolve lyophilized vaccine to original volume. It is based on esters of fatty the acids. The effectiveness--immunogenic activity--of the experimental preparation was compared with that of commercial rabies vaccines and the reference vaccine by means of the NIH and NRLR methods. The results obtained (2.826 units/cm3 by the NIH and 3.085 units/cm3 by the NRLR method) confirmed that the method of affinity chromatography could be used to prepare a rabies vaccine, exhibiting effectiveness superior to commercial preparations available, and complying with the WHO criteria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127580

Source DB:  PubMed          Journal:  Vet Med (Praha)        ISSN: 0375-8427            Impact factor:   0.558


  2 in total

1.  Risks related to a possible reduction of the waiting period for dogs after rabies antibody titration to 30 days compared with 90 days of the current EU legislative regime.

Authors:  Julio Alvarez; Søren Saxmose Nielsen; Emmanuelle Robardet; Arjan Stegeman; Steven Van Gucht; Vlad Vuta; Sotiria-Eleni Antoniou; Inma Aznar; Alexandra Papanikolaou; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-06-02

2.  Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain.

Authors:  Dong-Kun Yang; Ha-Hyun Kim; Yu-Ri Park; Jae Young Yoo; Yeseul Park; Sungjun An; Bang-Hun Hyun
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.